Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
ABGENIX INC (ABGX) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/29/2006 8-K Quarterly results
02/21/2006 8-K Quarterly results
Docs: "ABGENIX ANNOUNCES 2005 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS"
12/23/2005 8-K Other Events
12/19/2005 8-K Entry into a Material Definitive Agreement
12/15/2005 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger, among Amgen Inc., Athletics Merger Sub, Inc. and Abgenix, Inc",
"AMGEN TO ACQUIRE ABGENIX FOR $22.50 PER SHARE"
11/08/2005 8-K Other Events, Financial Statements and Exhibits
Docs: "PANITUMUMAB SIGNIFICANTLY IMPROVES PROGRESSION-FREE SURVIVAL IN PHASE 3 RANDOMIZED METASTATIC COLORECTAL CANCER STUDY"
10/25/2005 8-K Quarterly results
Docs: "Abgenix Announces Third Quarter 2005 Financial Results"
09/27/2005 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "Amended and Restated Bylaws of Abgenix, Inc"
08/02/2005 8-K Other Events, Financial Statements and Exhibits
Docs: "ABGENIX AND AMGEN ANNOUNCE FDA GRANTS PANITUMUMAB FAST TRACK DESIGNATION FOR METASTATIC COLORECTAL CANCER"
07/26/2005 8-K Quarterly results
Docs: "Abgenix Announces Second Quarter 2005 Financial Results"
06/28/2005 8-K Cost Associated with Exit or Disposal Activities, Financial Statements and Exhibits
Docs: "ABGENIX TO CONSOLIDATE RESEARCH FACILITIES IN PREPARATION FOR EXPANDED DEVELOPMENT AND COMMERCIAL OPERATIONS"
04/26/2005 8-K Quarterly results
Docs: "ABGENIX ANNOUNCES FIRST QUARTER 2005 FINANCIAL RESULTS"
03/24/2005 8-K Entry into a Material Definitive Agreement
02/22/2005 8-K Quarterly results
Docs: "ABGENIX ANNOUNCES 2004 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS"
02/18/2005 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
12/22/2004 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Indenture, between the Company and U.S. Bank National Association, as trustee",
"Registration Rights Agreement, between the Company and Goldman, Sachs & Co. on behalf of the initial purchasers"
12/16/2004 8-K Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits
Docs: "ABGENIX ANNOUNCES PRICING OF PRIVATE OFFERING OF CONVERTIBLE SENIOR NOTES"
12/15/2004 8-K Other Events, Financial Statements and Exhibits
Docs: "ABGENIX ANNOUNCES PROPOSED PRIVATE OFFERING OF CONVERTIBLE SENIOR NOTES"
10/26/2004 8-K Quarterly results
Docs: "Abgenix Announces Third Quarter 2004 Financial Results"
09/08/2004 8-K Appointed CFO
09/03/2004 8-K Entry into a Material Definitive Agreement
09/01/2004 8-K Entry into a Material Definitive Agreement
08/02/2004 8-K Other events, Financial statements and exhibits
Docs: "ABGENIX APPOINTS WILLIAM R. RINGO AS NEW CEO AND PRESIDENT"
07/27/2004 8-K Quarterly results
Docs: "ABGENIX ANNOUNCES SECOND QUARTER 2004 FINANCIAL RESULTS"
04/27/2004 8-K Quarterly results
Docs: "ABGENIX ANNOUNCES FIRST QUARTER 2004 FINANCIAL RESULTS"
03/17/2004 8-K Other events
02/24/2004 8-K Quarterly results
Docs: "ABGENIX ANNOUNCES 2003 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS"
10/29/2003 8-K Other events, Financial statements and exhibits
Docs: "ABGENIX AND ASTRAZENECA SUCCESSFULLY CLOSE EQUITY TRANSACTION FOR NEW ONCOLOGY ALLIANCE"
10/21/2003 8-K Quarterly results
Docs: "ABGENIX ANNOUNCES THIRD QUARTER 2003 FINANCIAL RESULTS"
10/16/2003 8-K Other events, Regulation FD Disclosure
Docs: "ASTRAZENECA AND ABGENIX ANNOUNCE STRATEGIC ALLIANCE TO DISCOVER AND DEVELOP ANTIBODY THERAPEUTICS FOR CANCER"
07/22/2003 8-K Financial statements and exhibits, Regulation FD Disclosure
Docs: "ABGENIX ANNOUNCES SECOND QUARTER 2003 FINANCIAL RESULTS"
04/23/2003 8-K Financial statements and exhibits, Regulation FD Disclosure
Docs: "ABGENIX ANNOUNCES FIRST QUARTER 2003 FINANCIAL RESULTS"
11/14/2002 8-K Financial statements and exhibits, Regulation FD Disclosure
Docs: "Certification of Raymond M. Withy, Ph.D. Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002",
"Certification of Kurt Leutzinger Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002"
08/14/2002 8-K Financial statements and exhibits, Regulation FD Disclosure
Docs: "Certification of Raymond M. Withy, Ph.D. Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002",
"Certification of Kurt Leutzinger Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy